Business Description
Valneva SE
ISIN : US92025Y1038
Share Class Description:
VALN: ADRTotal Employee Number:
674Compare
Compare
Traded in other countries / regions
VLA.FranceAYJ.GermanyVALN.USA0OB3.UKVLA.AustriaAYJ.Bulgaria IPO Date
2021-05-06Description
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.5 | |||||
Equity-to-Asset | 0.21 | |||||
Debt-to-Equity | 2.73 | |||||
Debt-to-EBITDA | -2.17 | |||||
Piotroski F-Score | 1/9 | |||||
Altman Z-Score | -1.82 | |||||
Beneish M-Score | -4.07 | |||||
WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -30.8 | |||||
3-Year EBITDA Growth Rate | 30.8 | |||||
3-Year EPS without NRI Growth Rate | 14.4 | |||||
3-Year FCF Growth Rate | 47.7 | |||||
3-Year Book Growth Rate | -27.2 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 16.58 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 54.8 | |||||
9-Day RSI | 49.42 | |||||
14-Day RSI | 45.92 | |||||
3-1 Month Momentum % | -14.64 | |||||
6-1 Month Momentum % | -45.28 | |||||
12-1 Month Momentum % | -8.57 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.14 | |||||
Quick Ratio | 1.6 | |||||
Cash Ratio | 1.12 | |||||
Days Inventory | 190.99 | |||||
Days Sales Outstanding | 53.1 | |||||
Days Payable | 62.57 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -7.8 | |||||
Shareholder Yield % | -2.97 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 29.46 | |||||
Operating Margin % | -63.56 | |||||
Net Margin % | -88.3 | |||||
EBITDA Margin % | -61.79 | |||||
FCF Margin % | -31.1 | |||||
OCF Margin % | -29.01 | |||||
ROE % | -99.3 | |||||
ROA % | -31.75 | |||||
ROIC % | -37.83 | |||||
3-Year ROIIC % | -18.07 | |||||
ROC (Joel Greenblatt) % | -53.12 | |||||
ROCE % | -30.11 | |||||
Years of Profitability over Past 10-Year | 1 | |||||
Moat Score | 6 | |||||
Tariff Resilience Score | 6 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 64.05 | |||||
PS Ratio | 2.52 | |||||
PB Ratio | 5.19 | |||||
Price-to-Tangible-Book | 7.16 | |||||
EV-to-EBIT | -5.85 | |||||
EV-to-EBITDA | -5.85 | |||||
EV-to-Revenue | 3.63 | |||||
EV-to-Forward-Revenue | 3.88 | |||||
EV-to-FCF | -11.67 | |||||
Price-to-GF-Value | 0.94 | |||||
Price-to-Median-PS-Value | 1.01 | |||||
Earnings Yield (Greenblatt) % | -17.09 | |||||
FCF Yield % | -10.46 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:VALN
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Valneva SE Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 181.828 | ||
| EPS (TTM) ($) | -1.866 | ||
| Beta | 0.5557 | ||
| 3-Year Sharpe Ratio | -0.3 | ||
| 3-Year Sortino Ratio | -0.42 | ||
| Volatility % | 83.18 | ||
| 14-Day RSI | 45.92 | ||
| 14-Day ATR ($) | 0.236702 | ||
| 20-Day SMA ($) | 5.287995 | ||
| 12-1 Month Momentum % | -8.57 | ||
| 52-Week Range ($) | 5.04 - 12.25 | ||
| Shares Outstanding (Mil) | 102.12 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Valneva SE Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Valneva SE Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-20 09:00 | In 135 days | ||
| Third quarter earnings results for 2026 | 2026-11-20 | In 134 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-12 | In 34 days | ||
| Second quarter earnings results for 2026 | 2026-08-12 | In 34 days | ||
| General meeting for 2026 | 2026-06-25 14:00 | 5.23 (-2.24%) | ||
| Jefferies Global Healthcare Conference | 2026-06-03 11:40 | 5.63 (-1.57%) | ||
| First quarter earnings conference call for 2026 | 2026-05-13 09:00 | 6.00 (+1.87%) | ||
| First quarter earnings results for 2026 | 2026-05-13 | 6.00 (+1.87%) | ||
| Van Lanschot Kempen Life Sciences Conference | 2026-04-15 | 6.09 (-2.72%) | ||
| Fourth quarter earnings conference call for 2025 | 2026-03-18 10:00 | 11.01 (+2.71%) |
Show
Entries
Valneva SE Frequently Asked Questions
What is Valneva SE(VALN)'s stock price today?
The current price of VALN is $5.30. The 52 week high of VALN is $12.25 and 52 week low is $5.04.
When is next earnings date of Valneva SE(VALN)?
The next earnings date of Valneva SE(VALN) is 2026-08-12 Est..
Does Valneva SE(VALN) pay dividends? If so, how much?
Valneva SE(VALN) does not pay dividend.
Guru Commentaries on NAS:VALN
No articles.
Press Release
Articles on Valneva SE
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers